Quantcast

Latest S. aureus Stories

2010-12-24 11:04:00

Baked goods and pastries may be repackaged, sold under other labels SILVER SPRING, Md., Dec. 24, 2010 /PRNewswire-USNewswire/ -- Fast Facts Rolf's Patisserie, a gourmet European style bakery located in Lincolnwood, Ill., is recalling all desserts made after Nov. 1, 2010. The products include tiramisu, cakes, cobblers, decorated cookies, tarts, pastries, and pies. The desserts have been connected to several outbreaks of Staphylococcus aureus (S. aureus) food poisoning. Because Rolf's...

290e55d30b3b8ddcca35fdca5614ca971
2010-12-15 16:31:39

Staphylococcus aureus bacteria bind best to human hemoglobin"Staph" bacteria feed on blood. They need the iron that's hidden away inside red blood cells to grow and cause infections. It turns out that these microbial vampires prefer the taste of human blood, Vanderbilt University scientists have discovered.The researchers report in the Dec. 16 issue of Cell Host & Microbe that Staphylococcus aureus (staph) favors human hemoglobin "“ the oxygen-carrying protein that contains iron...

2010-10-26 05:00:00

WAYNE, Pa. and LEUSDEN, Netherlands, Oct. 26 /PRNewswire/ -- Molecular Detection Inc. (MDI), a company developing Detect-Ready(TM) tests designed to increase the speed and accuracy of infectious disease diagnosis, and life sciences and diagnostics distributor Westburg BV today announced that they have entered into an exclusive agreement for distribution of MDI's Detect-Ready MRSA panel in the Benelux region. The Detect-Ready panel offers healthcare providers a high-performance MRSA...

2010-09-13 15:00:00

SAN DIEGO, Sept. 13 /PRNewswire-FirstCall/ -- Trius Therapeutics, Inc. (Nasdaq: TSRX) today reported new findings on torezolid phosphate (TR-701), a second generation oxazolidinone antibiotic now in Phase 3 clinical development. The data elucidate the mechanism by which torezolid retains full activity against clinical isolates of Staphylococcus aureus (S. aureus) carrying the cfr gene which confers resistance to first generation oxazolidinones such as linezolid, marketed by Pfizer as...

0cf8e9d6d63aa4675339c592f10ebf95
2010-09-02 11:00:00

New research expands the scope of previous pioneering work by Worcester Polytechnic Institute researchers on the mechanisms of bacterial infection Expanding their scope of study on the mechanisms of bacterial infection, researchers at Worcester Polytechnic Institute (WPI) have reported the surprise finding from a small clinical study that cranberry juice cocktail blocked a strain of Staphylococcus aureus (S. aureus) from beginning the process of infection. The data was reported in a poster...

2010-08-31 21:03:08

Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States. By neutralizing a key toxin associated with the bacteria, they found they could greatly reduce the damaging effects of the infection on skin and soft tissue. Community strains of S....

2010-05-21 05:00:00

SAN DIEGO, May 21 /PRNewswire-FirstCall/ -- Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus (S. aureus or "Staph") infections, including...

2010-04-10 05:00:00

CHAPEL HILL, N.C., Apr. 10 /PRNewswire/ -- Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102 (TAKSTA), the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease (ECCMID), April 10 to 13, 2010, in Vienna Austria. All presentations are scheduled for 12:30 to 1:30 p.m. CET on Sunday, April 11. CEM-101...

2009-12-10 07:00:00

WOBURN, Mass., and VEDBAEK, Denmark, Dec. 10 /PRNewswire/ -- AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its S. aureus PNA FISH® and S. aureus/CNS PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes. Clinical validation studies performed at hospitals in the United...

2009-10-28 23:01:00

CHAPEL HILL, N.C., Oct. 29 /PRNewswire/ -- Cempra Pharmaceuticals today announced data presentations of its lead antibiotic candidate, CEM-102 (fusidic acid), at the Infectious Diseases Society of America, 47th Annual Meeting, Oct. 29 to Nov. 1, 2009, in Philadelphia. Fusidic acid is a compound with an established record of treating staphylococcal infections, including methicillin-resistant S. aureus (MRSA), outside the U.S., a unique mechanism of action and low levels of bacterial...


Latest S. aureus Reference Libraries

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (1 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'